Reported Standalone quarterly numbers for Astec Lifesciences are:
Net Sales at Rs 110.79 crore in September 2023 down 44.54% from Rs. 199.75 crore in September 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 13.45 crore in September 2023 down 173.48% from Rs. 18.30 crore in September 2022.
EBITDA stands negative at Rs. 2.47 crore in September 2023 down 106.63% from Rs. 37.26 crore in September 2022.
Astec Life shares closed at 1,214.50 on October 30, 2023 (NSE) and has given -10.15% returns over the last 6 months and -43.98% over the last 12 months.
Story continues below Advertisement
| Astec Lifesciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'23 | Jun'23 | Sep'22 | | Net Sales/Income from operations | 110.79 | 142.85 | 199.75 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 110.79 | 142.85 | 199.75 | | EXPENDITURE | | Consumption of Raw Materials | 72.38 | 120.77 | 134.68 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 3.64 | -18.16 | -11.89 | | Power & Fuel | -- | -- | -- | | Employees Cost | 17.25 | 15.38 | 15.03 | | Depreciation | 9.17 | 9.40 | 8.18 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 20.94 | 21.72 | 28.64 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -12.59 | -6.27 | 25.10 | | Other Income | 0.96 | 1.70 | 3.98 | | P/L Before Int., Excpt. Items & Tax | -11.64 | -4.57 | 29.08 | | Interest | 6.00 | 6.47 | 4.52 | | P/L Before Exceptional Items & Tax | -17.64 | -11.03 | 24.56 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -17.64 | -11.03 | 24.56 | | Tax | -4.19 | -2.83 | 6.26 | | P/L After Tax from Ordinary Activities | -13.45 | -8.21 | 18.30 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -13.45 | -8.21 | 18.30 | | Equity Share Capital | 19.61 | 19.61 | 19.60 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -6.86 | -4.19 | 9.34 | | Diluted EPS | -6.86 | -4.19 | 9.33 | | EPS After Extra Ordinary | | Basic EPS | -6.86 | -4.19 | 9.34 | | Diluted EPS | -6.86 | -4.19 | 9.33 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
